therefore lysing the AML blast (blue arrow). This lysis is the definitive goal of an immune therapy for AML by using a defined T-cell epitope peptide derived from a LAA. AML: Acute myeloid ...

A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include ...

Medically reviewed by Benjamin Leach, MD Chronic myelomonocytic leukemia (CMML) is a rare cancer that begins in the ...

Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives ...

Pentixapharm said on Thursday it has begun treating patients in a Phase I/II trial of its radiopharmaceutical therapy Lu177-PentixaTher in adult patients with relapsed or refractory CXCR4-positive ...

immunosuppressive features facilitate expansion of the dysplastic clone and can eventually lead to disease progression to acute myeloid leukemia. Various cell types contribute to dysregulation of ...